Thiogenesis Therapeutics, Corp. (TTI.V)
TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
As of 01:45PM EDT. Market open.
| Previous Close | 0.4500 |
| Open | 0.4100 |
| Bid | 0.4050 x N/A |
| Ask | 0.5000 x N/A |
| Day's Range | 0.4200 - 0.4700 |
| 52 Week Range | 0.4000 - 0.7000 |
| Volume | |
| Avg. Volume | 28,625 |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Newsfile
Thiogenesis Announces Positive Results from Phase 1 Dose-Escalation Study of its Lead Compound TTI-0102
Data demonstrates potential for less frequent drug administrationTTI-0102 was well tolerated with no Serious Adverse Events reportedSupports EU and US regulatory submissions for human efficacy trials in multiple disease indicationsSan Diego, California--(Newsfile Corp. - May 18, 2022) - Thiogenesis Therapeutics, Corp. (TSXV: TTI) ("Thiogenesis" or the "Company") a clinical-stage biotechnology company developing sulfur-containing therapeutics for serious pediatric diseases, today announces positi
© 2022 Yahoo. All rights reserved.
